US2007027181A1PendingUtilityA1
Benzylisoquinoline derivative- or bisbenzylisoquinoline derivative-containing psychotropic agent, analgesic and/or antiphlogistic, and health food
Est. expiryAug 3, 2024(expired)· nominal 20-yr term from priority
A61P 25/18A61P 25/20A61P 29/00A61K 31/4709A61P 25/24A61K 31/472A61P 25/22A61P 25/04A61K 31/4725A61P 25/08C07D 217/20A61K 31/47
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A psychotropic agent, analgesic and/antiinflammatory agent, or health food which is safe even when taken for an extended period of term, comprising as an effective ingredient a benzylisoquinoline derivative represented by general formula (I): or a bisbenzylisoquinoline derivative represented by general formula (II): or a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modified1 - 42 . (canceled)
43 . A method for preventing and/or treating a pain and/or an inflammation, comprising administering to a patient in need thereof, as an effective ingredient, at least one compound selected from the group consisting of a benzylisoquinoline derivative represented by general formula (I):
wherein R 1 , R 2 and R 3 each independently represent a hydrogen atom, a C 1-6 alkyl group which may be substituted, an aryl group which may be substituted or a heteroaryl group which may be substituted, and X represents NR 4 or N + R 5 R 6 Y in which R 4 represents a hydrogen atom or a C 1-6 alkyl group, R 5 and R 6 each independently represent a hydrogen atom or a C 1-6 alkyl group, and Y represents a halide, hydroxide, or sulfate ion;
a bisbenzylisoquinoline derivative represented by general formula (II):
wherein R 7 , R 8 , R 9 , R 10 and R 11 each independently represent a hydrogen atom, a C 1-6 alkyl group which may be substituted, an aryl group which may be substituted or a heteroaryl group which may be substituted; and
a pharmaceutically acceptable salt thereof.
44 . The method of claim 43 , wherein a pain based on inflammation is prevented and/or treated.
45 . The method of claim 43 , wherein the compound represented by general formula (II) is neferine:
46 . The method of claim 43 , wherein said derivative is administered orally as part of a health food containing said derivative.
47 . The method of claim 46 , wherein the health food is a beverage or drinkable preparation.Join the waitlist — get patent alerts
Track US2007027181A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.